| Ytd | 18.16% | |
| 1y | -0.94% |
| Open | 12.23 | Prev Close | 12.12 | Low | 12.22 | High | 12.84 | Mkt Cap | 140.32M |
| Vol | 124.43K | Avg Vol | 214.17K | EPS | -1.23 | P/E | -10.26 | Forward P/E | 56.17 |
| Beta | 1.16 | Short Ratio | 7.68 | Inst. Own | 86.16% | Dividend | 6.60 | Div Yield | 34.41 |
| Ex Div Date | 09-18 | Earning | 05-04 | 50-d Avg | 11.11 | 200-d Avg | 11.20 | 1yr Est | 16.50 |
Medifast's low valuation and improving coach productivity offer potential, but a shrinking coach bas
Medifast stock gains 13.6% in a month as improving coach productivity and earnings expectations supp
Medifast's Trilivy launch and cost cuts could support a Q4 profit turnaround, but shrinking revenue
Medifast, Inc. has started to report stabilizing sales through improved coach productivity, shown ag
MED tops Q2 earnings expectations despite lower sales, as rising coach productivity helps offset pre
Medifast, Inc. (MED) Q2 2026 Earnings Call Transcript
Medifast NYSE: MED reported second-quarter 2026 revenue of $76.4 million, down 27.6% from a year ear
Medifast (MED) came out with a quarterly loss of $0.28 per share versus the Zacks Consensus Estimate
Gainers Medifast (NYSE:MED) stock increased by 10.7% to $10.78 during Monday's after-market ses
BALTIMORE--(BUSINESS WIRE)--Medifast (NYSE: MED), the health and wellness company known for its scie
MED's Q2 results are likely to face continued pressure from GLP-1 adoption and a smaller coach base,
Medifast (MED) possesses the right combination of the two key ingredients for a likely earnings beat
BALTIMORE--(BUSINESS WIRE)--Medifast (NYSE: MED), the metabolic health and wellness company known fo
Medifast's Trilivy expands beyond weight management with metabolic health support, personalized coac
The leading health and wellness company unveils an evolutionary transformation from weight loss to o
BALTIMORE--(BUSINESS WIRE)--Medifast, Inc. (NYSE: MED) today announced the launch of Trilivy, a comp
The heavy selling pressure might have exhausted for Medifast (MED) as it is technically in oversold
The weight loss and weight management market was valued at $31.07 billion in 2025 A program can des
OPTAVIA's clinical program reduces visceral fat 14% and retains 98% lean mass, directly addressing t
Medifast (MED) reported earnings 30 days ago. What's next for the stock?
Here is how Medifast (MED) and New York Times Co. (NYT) have performed compared to their sector so f
BALTIMORE--(BUSINESS WIRE)--Medifast, Inc. (NYSE: MED) today announced that its Board of Directors h
A randomized controlled trial published in Obesity Science & Practice found that clients on the OPTA
70% of users discontinued use of lifestyle behavior and health apps within the first 100 days (Kidma
The global weight loss industry was valued at $16.3 billion in 2025, yet peer-reviewed clinical vali
All three major U.S. indices are red in Wednesday's midday trading as investors weighed Presiden
Companies Reporting Before The Bell • Barclays (NYSE:BCS) is likely to report quarterly earnings at
On Thursday, 930 stocks hit new 52-week lows.
On Tuesday, 400 companies set new 52-week lows.
This morning 792 companies reached new 52-week highs.
This morning 533 companies reached new 52-week highs.
On Tuesday, 596 companies set new 52-week highs.
Monday morning saw 558 companies set new 52-week highs.
Stocks That Hit 52-Week Lows On Thursday
Stocks That Hit 52-Week Lows On Monday
Stocks That Hit 52-Week Lows On Thursday